Pfizer Ltd
Ticker: PFIZER
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
5209.00
Market Cap
23829.99
Debt/Equity
0.0097
ROE %
19.649
PB
5.6504
Promoter %
63.922
Pledge %
0.000
1Y Rev Growth %
10.278
5Y Rev Growth %
2.374
NP Margin %
29.226
NP Margin 5Y Avg %
24.224
Trading Reference
1M Return %
1.132
6M Return %
21.218
1Y Return %
2.179
% Away 52W High
15.051
% Away 52W Low
40.746
Daily Volume
11482
Investment Verdict
Risky
Score 58/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 47/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
D
Deepak Nitrite Ltd
Deepak Nitrite Ltd shows decent potential with consistent growth, but faces valuation concerns and execution risks.
View details
S
SKF India Ltd
SKF India Ltd shows decent potential with stable growth prospects, but faces challenges in profitability and valuation metrics.
View details
K
KEC International Ltd
KEC International Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
N
Nuvama Wealth Management Ltd
Nuvama Wealth Management Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
H
Himadri Speciality Chemical Ltd
Himadri Speciality Chemical Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
W
Welspun Corp Ltd
Welspun Corp Ltd shows potential but faces challenges in growth consistency and execution risks. It is advisable to monitor closely before making investment decisions.
View details
B
Brigade Enterprises Ltd
Brigade Enterprises Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
D
Devyani International Ltd
Devyani International Ltd shows decent potential with growth opportunities, but faces challenges in profitability and valuation metrics.
View details
C
CPSE ETF
The CPSE ETF presents a decent investment opportunity, but investors should be cautious about growth consistency and underlying risks.
View details
B
Bayer Cropscience Ltd
Bayer Cropscience Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for new investments.
View details
E
Eris Lifesciences Ltd
Eris Lifesciences Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in valuation and execution risks.
View details
T
Timken India Ltd
Timken India Ltd shows a decent investment opportunity with consistent growth and profitability metrics, though some risks remain in execution and governance.
View details
A
Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
C
Chalet Hotels Ltd
Chalet Hotels Ltd shows potential for growth in a recovering sector, but faces challenges in profitability and valuation metrics.
View details
M
Mangalore Refinery and Petrochemicals Ltd
Mangalore Refinery and Petrochemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
K
Kalpataru Projects International Ltd
Kalpataru Projects International Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and execution risks.
View details
Business Overview
Pfizer Ltd is a leading pharmaceutical company dedicated to improving health and well-being across India. With a strong focus on research and innovation, Pfizer develops a wide range of medicines and vaccines that cater to various health needs. This makes it an essential partner for healthcare professionals and patients alike. By prioritizing quality and accessibility, Pfizer plays a crucial role in enhancing the quality of life for millions.
- Established leader in pharmaceuticals
- Innovative vaccines and medicines
- Focus on quality and accessibility
- Committed to improving public health
- Trusted by healthcare professionals
Investment Thesis
Pfizer Ltd stands out as a compelling investment due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. These factors position the company for sustained performance and resilience in the evolving healthcare landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment poised for substantial growth, tapping into market demand.
- Attractive valuation metrics compared to industry peers offer a favorable entry point.
- Robust pipeline of innovative products supports long-term revenue growth.
- Commitment to R&D ensures competitive edge in the pharmaceutical sector.
Opportunity vs Risk
Opportunities
- Strong vaccine portfolio
- Growing biopharmaceutical pipeline
- Expansion in emerging markets
- Strategic partnerships and collaborations
Risks ⚠️
- Regulatory scrutiny on drugs
- Patent expirations impact revenue
- Competition from generic drugs
- Market volatility affecting stock price
Peer Perspective
Pfizer Ltd trades at a slight premium compared to peers like Sun Pharmaceutical and Cipla, reflecting its robust growth prospects. A sustained improvement in margins could trigger a rerating, aligning it closer to industry leaders.
Future Outlook
Pfizer Ltd is well-positioned for growth, driven by its robust pipeline and ongoing innovation. However, successful execution and effective cost control will be crucial to fully realize its potential in the coming years.
AI FAQs for Retail Users
- Q: What does Pfizer Ltd do?A: Pfizer Ltd focuses on developing and manufacturing pharmaceuticals and vaccines for various health conditions.
- Q: Is Pfizer Ltd a good investment?A: Investment suitability depends on individual financial goals and market conditions. Always conduct thorough research.
- Q: What are the risks of investing in Pfizer Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical industry.
- Q: How can I buy shares of Pfizer Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: Does Pfizer Ltd pay dividends?A: Pfizer Ltd has historically paid dividends, but payment amounts can vary based on company performance.
📊 Stock Investment Checklist (100 Points)
Pfizer Ltd • Updated: 2025-09-17 06:10:23
-
10BusinessHighPharmaceutical sector is stable but faces regulatory challenges.
-
10GrowthHighConsistent revenue growth driven by new product launches.
-
10ProfitabilityHighStrong ROE and OCF, but net profit margins are under pressure.
-
8ValuationHighP/E and P/B ratios are higher than industry averages.
-
7BalanceHighModerate debt levels with adequate liquidity.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodPotential growth from new therapies, but execution risks are present.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Pfizer Ltd shows decent potential with consistent growth, but faces valuation challenges and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 65/100
- Market Confidence: 72/100